Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide

about

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide

Item

http://www.wikidata.org/entity/Q26751359

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Combination therapies in the m ...... f insulin degludec/liraglutide

@ast

Combination therapies in the m ...... f insulin degludec/liraglutide

@en

Combination therapies in the m ...... f insulin degludec/liraglutide

@nl

type

Item

label

Combination therapies in the m ...... f insulin degludec/liraglutide

@ast

Combination therapies in the m ...... f insulin degludec/liraglutide

@en

Combination therapies in the m ...... f insulin degludec/liraglutide

@nl

prefLabel

Combination therapies in the m ...... f insulin degludec/liraglutide

@ast

Combination therapies in the m ...... f insulin degludec/liraglutide

@en

Combination therapies in the m ...... f insulin degludec/liraglutide

@nl

P1476

Combination therapies in the m ...... f insulin degludec/liraglutide

@en

P2093

Lisa M Chastain

http://www.w3.org/2001/XMLSchema#string

Molly G Minze

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

A review of the pharmacological properties of insulin degludec and their clinical relevance.

Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial.

A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.

Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens.

Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes

IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy.

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

Insulin degludec improves health-related quality of life (SF-36® ) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials.

P304

471-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5012942

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/TCRM.S73579

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27099505

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

Insulin

P932

4820208

http://www.w3.org/2001/XMLSchema#string